28 April 2021 - How much muscle did Congress invest in a pair of bills recently signed by President Biden? The answer may lie in your willingness to believe.

Two much touted bills for biologics and biosimilar advancement went to President Joe Biden’s desk for signing recently and were approved, but the devil is in the details, and whether they are going to have a tangible effect on biosimilar access is debatable.

Read Center for Biosimilars article